Oncology: European society guidelines
71 current official documents on oncology from European societies, in PDF. Sources: ESMO (71).
Sign up for our AI library search toolSign up →Oncology in other countries
See also
71 documents
Oncology71
- Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment of metastatic pancreatic cancerEurope · ESMO · 2026PDF ↗
- Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2026PDF ↗
- 2303P Barriers related to adherence and implementation of the ESMO clinical practice guidelines: A survey provided by the ESMO community oncologists task forceEurope · ESMO · 2025PDF ↗
- Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2025PDF ↗
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinomaEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemiaEurope · ESMO · 2024PDF ↗
- ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemiaEurope · ESMO · 2024PDF ↗
- Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2024PDF ↗
- Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to ‘Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up’)Europe · ESMO · 2023PDF ↗
- Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2023PDF ↗
- Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agentsEurope · ESMO · 2023PDF ↗
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineEurope · ESMO · 2023PDF ↗
- 1586P Improving the management of anaemia in cancer patients receiving chemotherapy: ESMO clinical practice guidelines in actionEurope · ESMO · 2022PDF ↗
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancerEurope · ESMO · 2022PDF ↗
- Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEurope · ESMO · 2022PDF ↗
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice GuidelineEurope · ESMO · 2022PDF ↗
- Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Europe · ESMO · 2021PDF ↗
- Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2021PDF ↗
- EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumoursEurope · ESMO · 2021PDF ↗
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerEurope · ESMO · 2021PDF ↗
- Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†Europe · ESMO · 2021PDF ↗
- Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2021PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerEurope · ESMO · 2021PDF ↗
- Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancerEurope · ESMO · 2021PDF ↗
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice GuidelinesEurope · ESMO · 2021PDF ↗
- Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice GuidelinesEurope · ESMO · 2021PDF ↗
- Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Bone health in cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2020PDF ↗
- Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatmentEurope · ESMO · 2020PDF ↗
- Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†Europe · ESMO · 2020PDF ↗
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSEurope · ESMO · 2020PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSOEurope · ESMO · 2020PDF ↗
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2020PDF ↗
- Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSEurope · ESMO · 2019PDF ↗
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSEurope · ESMO · 2019PDF ↗
- Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancerEurope · ESMO · 2019PDF ↗
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2019PDF ↗
- Delirium in adult cancer patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Diarrhoea in adult cancer patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Management of cancer pain in adult patients: ESMO Clinical Practice GuidelinesEurope · ESMO · 2018PDF ↗
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗
- Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upEurope · ESMO · 2018PDF ↗